<DOC>
	<DOCNO>NCT02349893</DOCNO>
	<brief_summary>The United States currently experience increase incidence prevalence obstructive sleep apnea ( OSA ) . With prevalence middle-aged adult 2 4 % population , untreated OSA implicate increase risk cardiovascular disease , include hypertension heart failure , daytime sleepiness , increase risk motor vehicle accident . This study design order evaluate CelonProSleep plus multi-level radiofrequency ablation ( RFA ) palate base tongue treatment mild moderate obstructive sleep apnea syndrome ( OSAS ) .</brief_summary>
	<brief_title>Radiofrequency Ablation Multi-level Obstructive Sleep Apnea : A Single-arm , Multicenter Study</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>Adults ( ≥ 22 year ) Selfreport daytime somnolence Body mass index ( BMI ) ≤ 32 Mild moderate obstructive sleep apnea ( AHI 10 30 ; low O2 sit ≥ 80 % ) Evidence palate tongue base collapse supine fiberoptic examination Noncompliant refusal continuous positive airway pressure therapy ( CPAP ) ( &lt; 4 hour per night patient report ) No prior surgical treatment OSAS nasal surgery Willing capable providing inform consent Another significant sleep disorder ( e.g. , insomnia , periodic limb movement ) Tonsillar hypertrophy Chronic Obstructive Pulmonary Disease ( COPD ) Interstitial Lung Disease ( ILD ) Cystic Fibrosis Acute Repiratory Distress Syndrome ( ARDS ) Nasal supraglottic obstruction fiberoptic examination American Society Anesthesiologists ( ASA ) class III , IV , V Latex allergy Lidocaine allergy Pregnancy plan become pregnant Note : woman childbearing potential must demonstrate negative pregnancy test upon enrollment ; patient qualify progress RFA must also demonstrate negative pregnancy test within 7 day prior date RFA procedure . Major depression nonstabilized psychiatric disorder Drug alcohol abuse Previous palatal tongue surgery Stable unstable angina congestive heart failure ( CHF ) moderate severe valvular disease transient ischemic attack ( TIA ) /cardiovascular accident ( CVA ) Carotid stenosis endarterectomy Anemia Room air oxygen saturation ( SpO2 ) &lt; 95 % Pulmonary hypertension Dialysis Central mixed apnea ≥ 10 % respiratory event Participation another clinical study ( enrol concurrent study ) whose investigational plan judge interfere affect measure study</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>